Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT05017584 Withdrawn - Pain Clinical Trials

ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)

Start date: January 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the dose of bupivacaine that provides effective pain management in 90% (ED90) of patients undergoing bilateral tubal ligation. This will guide anesthesiologists on the most effective dose to minimize intraoperative pain during this procedure. The goal is to make women as comfortable as possible when they undergo this procedure while also minimizing the amount of time they are required to remain in the hospital afterwards for monitoring.

NCT ID: NCT05013840 Completed - Pain Clinical Trials

Opinions of Healthcare Providers About Neuromodulation

Start date: September 2, 2021
Phase:
Study type: Observational

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to healthcare providers.

NCT ID: NCT05013827 Completed - Pain Clinical Trials

Opinions of Company Representatives About Neuromodulation

Start date: September 2, 2021
Phase:
Study type: Observational

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.

NCT ID: NCT05012904 Completed - Pain Clinical Trials

Using Parental Involvement During Venipuncture to Reduce Venipuncture Pain and Anxiety in Children With Cancer

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims to determine whether parental involvement during venipuncture reduces venipuncture pain and anxiety in children with cancer.

NCT ID: NCT05007041 Completed - Pain Clinical Trials

Simultaneous RZV and aIIV4 Vaccination

Start date: September 21, 2021
Phase: Phase 4
Study type: Interventional

The overall aim of the study is to compare the safety of simultaneous Zoster Vaccine Recombinant, Adjuvanted (RZV) (SHINGRIX®) and Quadrivalent Influenza Vaccine, Adjuvanted (FLUAD®) versus simultaneous Zoster Vaccine Recombinant, Adjuvanted (RZV) (SHINGRIX®) and Fluzone® High-Dose Quadrivalent vaccine in persons age ≥65 years. A prospective, randomized, blinded clinical trial that will be conducted during the 2021/2022 and 2022/2023 influenza seasons. Over the course of these two influenza seasons, approximately 220 older adults will be enrolled at Duke University Medical Center, and 180 older adults at Johns Hopkins University Medical Center. Eligible subjects will be randomized to receive either simultaneous RZV/FLUAD® or RZV/Fluzone® High-Dose vaccines. All subjects will be assessed for 7 days post-injection and safety and tolerability compared between the two groups. Serious adverse events and adverse events of clinical interest will be assessed 42 days post-vaccination and compared between the two groups. Health-related quality of life will be assessed pre-vaccination Day 1 through Day 8. Serious Adverse Events and Adverse Events of Clinical Interest were also assessed throughout the study period.

NCT ID: NCT05006976 Active, not recruiting - Depression Clinical Trials

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

NSAC
Start date: September 6, 2021
Phase: N/A
Study type: Interventional

The Norwegian Sickness Absence Clinic (NSAC) Nudge Study is a naturalistic randomized controlled multicentre trial which aim is to measure the efficacy of nudging clinicians' attention towards patients' motivation for work, barriers for return to work and work environment challenges, on functional recovery as primary outcome, and health outcomes as secondary outcome. Patients will be recruited in five different NSACs across northern Norway. In total 1100 patients will be randomized to two equal probability treatment arms: 1) NSAC with the nudge, and 2) NSAC without the nudge. The nudge is tailored to the individual patient's needs using survey, and the clinicians are presented with a summary of this patient survey prior to consultations highlighting health problems and challenges as reported by the patient in the survey.

NCT ID: NCT05004766 Not yet recruiting - Pain Clinical Trials

Effects of Virtual Reality Application on Pain Reduction and Cerebral Blood Flow in Robot Training in Burn Patients

Start date: August 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the application of virtual reality (VR) is effective in reducing training pain in robot-assisted gait training (RAGT) in patients with lower extremity burn. The investigators investigated through an analysis of the activation status over time in the prefrontal cortex using functional near-infrared spectroscopy (NIRS).

NCT ID: NCT05003882 Completed - Pain Clinical Trials

Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting

RWE-ACES
Start date: August 2, 2021
Phase:
Study type: Observational

A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.

NCT ID: NCT05003661 Completed - Pain Clinical Trials

The Effects of the Parents' Voice to Reduce the Heel Puncture Pain in High-Risk Neonates

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

High-risk neonates are forced to be separated from their parents due to hospitalization, and clinical medical treatment often causes pain and physical stress in high-risk newborns. Many literatures have confirmed that the mother's voice is positively helpful to the physiology of high-risk newborns, but few studies have been conducted on the father's voice. However, the parenting process is not only a link between the mother-child relationship, but also the impact of parental voice on high-risk newborns infants. Parent roles are expecting. The purpose of this study is to explore the effectiveness of parental voice intervention in high-risk newborns' heel puncture in reducing pain, and to further compare the mother and father's voice characteristics to the analysis of the pain degree of high-risk newborns.

NCT ID: NCT04994249 Recruiting - Pain Clinical Trials

Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation

Start date: March 21, 2022
Phase:
Study type: Observational

To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.